InfuSystem Holdings (INFU) Revenue Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.05% |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn | 5.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.19% |
| Mar 31, 2026 | 3.51% |
| Dec 31, 2025 | 7.91% |
| Sep 30, 2025 | 10.18% |
| Jun 30, 2025 | 10.01% |
| Mar 31, 2025 | 9.06% |
| Dec 31, 2024 | 8.45% |
| Sep 30, 2024 | 9.96% |
| Jun 30, 2024 | 10.71% |
| Mar 31, 2024 | 9.36% |
| Dec 31, 2023 | 8.74% |
| Sep 30, 2023 | 8.29% |
| Jun 30, 2023 | 6.87% |
| Mar 31, 2023 | 12.11% |
| Dec 31, 2022 | 9.92% |
| Sep 30, 2022 | 8.28% |
| Jun 30, 2022 | 11.09% |
| Mar 31, 2022 | 13.73% |
| Dec 31, 2021 | 14.75% |
| Sep 30, 2021 | 16.79% |